Nanodrops News
4 articles
growth-positive
/PRNewswire/ -- NanoDrops, an Israeli med-tech company developing one-of-a-kind vision correction technology, today announced that it is appointing Daria...
NanoDrops, an Israeli med-tech company specializing in vision correction technology, has appointed Daria Lemann-Blumenthal as its new CEO. Lemann-Blumenthal, who previously led BELKIN Vision to a successful acquisition by Alcon, brings extensive experience in the ophthalmic industry. NanoDrops is developing a minimally-invasive vision correction technology using laser tech and nanoparticles, targeting presbyopia and myopia. The company is backed by Sanara Capital and is preparing for human clinical trials. The appointment of Lemann-Blumenthal is seen as a strategic move to propel NanoDrops through its next growth phase, with a focus on clinical studies and market engagement.
Management ChangesInvestment
These Nanodrops Could Mean The End Of Glasses Forever
growth-positive
Using "Nanodrops" to Repair Corneas Could Ultimately Replace Glasses
Researchers from the Shaare Zedek Medical Center and Bar-Ilan University in Israel have developed nanodrops that can improve both nearsightedness and farsightedness. The drops have been successfully tested on pigs corneas. The drops use nanotechnology to improve vision and have the potential to replace multifocal lenses. Patients would use an app to measure their eyes refraction and create a laser pattern to be stamped onto the corneal surface. The frequency of application and additional work needed before human trials were not discussed. The article highlights ongoing research in the field of vision improvement, including stem cell treatment for macular degeneration and the development of a bionic eye by the Ocumetics Technology Corporation.
Customers
growth-positive
https://www.jpost.com/HEALTH-SCIENCE/New-eyedrops-could-repair-corneas-make-glasses-unneccessary-543344
A researcher at Shaare Zedek Medical Center and Bar-Ilan University has invented and patented nanodrops that have shown improvements in vision when tested on pigs corneas. If successful in human clinical testing, these nanoparticle drops could potentially eliminate the need for eyeglasses. The drops were developed at Bar-Ilan Universitys Institute of Nanotechnology and Advanced Materials and have the potential to revolutionize the treatment of refractory eye conditions. The drops would be applied using a smartphone application and laser corneal stamping. The research was presented at Shaare Zedeks biennial research day.
Customers
